Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Obstructive Lung Diseases

  Free Subscription


27.06.2022

1 Allergy
5 Am J Respir Crit Care Med
2 Ann Allergy Asthma Immunol
5 Arch Bronconeumol
1 Arch Dis Child
2 Can Respir J
1 Clin Exp Allergy
2 Eur Respir J
1 J Allergy Clin Immunol
5 J Asthma
2 J Investig Allergol Clin Immunol
4 J Pediatr
1 Occup Environ Med
3 Pediatr Pulmonol
1 PLoS One
2 Respir Med
3 Respir Res
7 Thorax


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Allergy

  1. RADZIKOWSKA U, Baerenfaller K, Cornejo-Garcia JA, Karaaslan C, et al
    Omics technologies in allergy and asthma research: an EAACI position paper.
    Allergy. 2022 Jun 17. doi: 10.1111/all.15412.
    PubMed         Abstract available


    Am J Respir Crit Care Med

  2. PERSSON C
    Susceptibility of Patients with Asthma to Poor Outcome of COVID-19.
    Am J Respir Crit Care Med. 2022 Jun 23. doi: 10.1164/rccm.202205-0978.
    PubMed        

  3. CALVERLEY P
    Lessons from the North: CanCOLD, Exercise, and Chronic Obstructive Pulmonary Disease.
    Am J Respir Crit Care Med. 2022;205:1369-1370.
    PubMed        

  4. ZHU M, Huang Y, Ma H, Shen H, et al
    Reply to: Contribution of COPD as a Mediator for the Association Between Air Pollution and Lung Cancer.
    Am J Respir Crit Care Med. 2022 Apr 23. doi: 10.1164/rccm.202202-0283.
    PubMed        

  5. BUI DS, Liu J, Dharmage SC, Perret JL, et al
    Contribution of COPD as a Mediator for the Association Between Air Pollution and Lung Cancer.
    Am J Respir Crit Care Med. 2022 Apr 23. doi: 10.1164/rccm.202112-2681.
    PubMed        

  6. PHILLIPS DB, Elbehairy AF, James MD, Vincent SG, et al
    Impaired Ventilatory Efficiency, Dyspnea, and Exercise Intolerance in Chronic Obstructive Pulmonary Disease: Results from the CanCOLD Study.
    Am J Respir Crit Care Med. 2022;205:1391-1402.
    PubMed         Abstract available


    Ann Allergy Asthma Immunol

  7. DINWIDDIE DL, Kaukis N, Pham S, Hardin O, et al
    Viral infection and allergy status impact severity of asthma symptoms in children with asthma exacerbations.
    Ann Allergy Asthma Immunol. 2022 Jun 21. pii: S1081-1206(22)00535.
    PubMed         Abstract available

  8. PANETTIERI RA JR, Ledford DK, Chipps BE, Soong W, et al
    Biologic Use and Outcomes Among Adults with Severe Asthma Treated by United States Subspecialists.
    Ann Allergy Asthma Immunol. 2022 Jun 18. pii: S1081-1206(22)00532.
    PubMed         Abstract available


    Arch Bronconeumol

  9. MARTINEZ-VERGARA A, Giron RM, Churruca-Arrospide M, Lopez-Pereira P, et al
    Clinical course of patients with bronchiolitis obliterans following hematopoietic stem cell transplantation.
    Arch Bronconeumol. 2021;57:664-666.
    PubMed        

  10. LOPEZ-CAMPOS JL, Calle Rubio M, Izquierdo Alonso JL, Fernandez-Villar A, et al
    Forum COPD working group consensus on the diagnosis, treatment and follow-up of COPD.
    Arch Bronconeumol. 2021;57:596-599.
    PubMed        

  11. ALONSO-PEREZ T, Garcia-Castillo E, Lopez-Campos JL
    Escalation and de-escalation of therapy in chronic obstructive pulmonary disease. Is the inhaler important?
    Arch Bronconeumol. 2021;57:604-605.
    PubMed        

  12. KATSOULIS K, Kipourou M, Quaranta Vitaliano N, Kostikas K, et al
    Predicting Bronchial Hyperresponsiveness in Patients with Asthma: The Role of Impulse Oscillometry.
    Arch Bronconeumol. 2022 Jun 2. pii: S0300-2896(22)00438.
    PubMed        

  13. PASCUAL S, Dorado S, Urrutia I
    Physical Activity and Asthma.
    Arch Bronconeumol. 2022 May 17. pii: S0300-2896(22)00342.
    PubMed        


    Arch Dis Child


  14. Does the measurement of fractional exhaled nitric oxide help asthma management?
    Arch Dis Child. 2022;107:699.
    PubMed        


    Can Respir J

  15. LIU C, Ran R, Li X, Liu G, et al
    Genetic Variants Associated with Chronic Obstructive Pulmonary Disease Risk: Cumulative Epidemiological Evidence from Meta-Analyses and Genome-Wide Association Studies.
    Can Respir J. 2022;2022:3982335.
    PubMed         Abstract available

  16. QIU Y, Wang Y, Shen N, Wang Q, et al
    Nomograms for Predicting Coexisting Cardiovascular Disease and Prognosis in Chronic Obstructive Pulmonary Disease: A Study Based on NHANES Data.
    Can Respir J. 2022;2022:5618376.
    PubMed         Abstract available


    Clin Exp Allergy

  17. CHAN R, Lipworth BJ
    Oscillometry bronchodilator response in adult moderate to severe eosinophilic asthma patients: A prospective cohort study.
    Clin Exp Allergy. 2022 Jun 16. doi: 10.1111/cea.14185.
    PubMed        


    Eur Respir J

  18. SHOEMARK A, Griffin H, Wheway G, Hogg C, et al
    Genome sequencing reveals underdiagnosis of primary ciliary dyskinesia in bronchiectasis.
    Eur Respir J. 2022 Jun 21. pii: 13993003.00176-2022.
    PubMed         Abstract available

  19. CHANG AB, Zacharasiewicz A, Goyal V, Boyd J, et al
    Task Force report: European Respiratory Society statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials.
    Eur Respir J. 2022 Jun 21. pii: 13993003.00300-2022.
    PubMed         Abstract available


    J Allergy Clin Immunol

  20. SHARMA S, Yang IV, Schwartz DA
    Epigenetic regulation of immune function in asthma.
    J Allergy Clin Immunol. 2022 Jun 15. pii: S0091-6749(22)00763.
    PubMed         Abstract available


    J Asthma

  21. SHINKAI M, Ebisawa M, Fukushima Y, Takeuchi S, et al
    One-year safety and tolerability of tezepelumab in Japanese patients with severe uncontrolled asthma: results of the NOZOMI study.
    J Asthma. 2022 Jun 16:1-9. doi: 10.1080/02770903.2022.2082309.
    PubMed         Abstract available

  22. RADPARVAR I, Ross MK
    Barriers and facilitators of electronic patient portal uptake for asthma management.
    J Asthma. 2022 Jun 20:1-12. doi: 10.1080/02770903.2022.2087190.
    PubMed         Abstract available

  23. ZBIGNIEW D, Magdalena OG, Piotr H, Agnieszka AR, et al
    The assessment of effectiveness, tolerance, and patient satisfaction with the use of a new fixed-dose combination product, containing salmeterol and fluticasone propionate, Salflumix Easyhaler(R) in the treatment of asthma in the daily clinical practi
    J Asthma. 2022 Jun 22:1-13. doi: 10.1080/02770903.2022.2093220.
    PubMed         Abstract available

  24. O'CONNELL S, Queally M, Savage E, Murphy DM, et al
    Preferences for support in managing symptoms of an asthma flare-up: a pilot study of a discrete choice experiment.
    J Asthma. 2022 Jun 24:1-10. doi: 10.1080/02770903.2022.2054429.
    PubMed         Abstract available

  25. CHEN KY, Chu W, Jones R, Vuillermin P, et al
    Modifiable factors associated with pediatric asthma readmissions: a multi-center linked cohort study.
    J Asthma. 2022 Jun 24:1-10. doi: 10.1080/02770903.2022.2089996.
    PubMed         Abstract available


    J Investig Allergol Clin Immunol

  26. POSE K, Laorden D, Hernandez N, Villamanan E, et al
    Concomitant Efficacy of Dupilumab for severe atopic dermatitis and comorbid asthma in real-life conditions.
    J Investig Allergol Clin Immunol. 2022 Jun 20:0. doi: 10.18176/jiaci.0837.
    PubMed        

  27. OLAGUIBEL JM, Sastre J, Rodriguez JM, Del Pozo V, et al
    Eosinophilia Induced by Blocking the IL-4/IL-13 Pathway: Potential Mechanisms and Clinical Outcomes.
    J Investig Allergol Clin Immunol. 2022;32:165-180.
    PubMed         Abstract available


    J Pediatr

  28. OJUGBELE O, Poitevien P
    A novel Health Disparities Index and acute asthma management.
    J Pediatr. 2022;245:246-249.
    PubMed        

  29. ZHAO X
    Specialist visit associated with improved asthma outcomes.
    J Pediatr. 2022;245:246-249.
    PubMed        

  30. WECHSLER M
    Dupilumab reduces severe asthma exacerbations.
    J Pediatr. 2022;245:246-249.
    PubMed        

  31. CAMPBELL JI, Dubois MM, Savage TJ, Hood-Pishchany MI, et al
    Comorbidities Associated with Hospitalization and Progression Among Adolescents with Symptomatic Coronavirus Disease 2019.
    J Pediatr. 2022;245:102-110.
    PubMed         Abstract available


    Occup Environ Med

  32. ALHANTI B, van Wendel de Joode B, Soto Martinez M, Mora AM, et al
    Environmental exposures contribute to respiratory and allergic symptoms among women living in the banana growing regions of Costa Rica.
    Occup Environ Med. 2022;79:469-476.
    PubMed         Abstract available


    Pediatr Pulmonol

  33. ALLAER L, Lejeune S, Mordacq C, Deschildre A, et al
    Primary ciliary dyskinesia and fungal infections: Two cases of allergic bronchopulmonary aspergillosis in children.
    Pediatr Pulmonol. 2022;57:1809-1813.
    PubMed         Abstract available

  34. ZAITSU M, Matsuo M
    Transient low IgG4 levels cause recurrent wheezing requiring multiple hospitalizations in infancy.
    Pediatr Pulmonol. 2022 Apr 18. doi: 10.1002/ppul.25927.
    PubMed         Abstract available

  35. MATERA L, Nenna R, Frassanito A, Petrarca L, et al
    Low lymphocyte count: a clinical severity marker in infants with bronchiolitis.
    Pediatr Pulmonol. 2022 Apr 11. doi: 10.1002/ppul.25919.
    PubMed         Abstract available


    PLoS One

  36. FENG S, Yuan J, Zhao D, Li R, et al
    Systematic characterization of the effective constituents and molecular mechanisms of Ardisiae Japonicae Herba using UPLC-Orbitrap Fusion MS and network pharmacology.
    PLoS One. 2022;17:e0269087.
    PubMed         Abstract available


    Respir Med

  37. LEONARD SI, Turi ER, Powell JS, Usseglio J, et al
    Associations of asthma self-management and mental health in adolescents: A scoping review.
    Respir Med. 2022;200:106897.
    PubMed         Abstract available

  38. LUOTO J, Pihlsgard M, Pistolesi M, Paoletti M, et al
    Emphysema severity index (ESI) associated with respiratory death in a large Swedish general population.
    Respir Med. 2022;200:106899.
    PubMed         Abstract available


    Respir Res

  39. LE NPK, do Nascimento AF, Schneberger D, Quach CC, et al
    Deficiency of leukocyte-specific protein 1 (LSP1) alleviates asthmatic inflammation in a mouse model.
    Respir Res. 2022;23:165.
    PubMed         Abstract available

  40. MARIN-OTO M, Sanz-Rubio D, Santamaria-Martos F, Benitez I, et al
    Soluble RAGE in COPD, with or without coexisting obstructive sleep apnoea.
    Respir Res. 2022;23:163.
    PubMed         Abstract available

  41. QIN W, Huang H, Dai Y, Han W, et al
    Proteome analysis of urinary biomarkers in a cigarette smoke-induced COPD rat model.
    Respir Res. 2022;23:156.
    PubMed         Abstract available


    Thorax

  42. NAIR AA, Rv L, Christopher DJ
    'Pulmonary tuberculosis presenting as massive spontaneous pneumomediastinum and subcutaneous emphysema'.
    Thorax. 2022 Jun 16. pii: thoraxjnl-2022-218908.
    PubMed        

  43. WU CC, Wang CC, Chung WY, Sheu CC, et al
    Environmental risks and sphingolipid signatures in adult asthma and its phenotypic clusters: a multicentre study.
    Thorax. 2022 Jun 16. pii: thoraxjnl-2021-218396.
    PubMed         Abstract available

  44. D'CRUZ RF, Kaltsakas G
    Does impaired respiratory function lead to sudden cardiac death?
    Thorax. 2022;77:641-642.
    PubMed        

  45. NICI L
    Improving the lives of individuals with chronic respiratory disease: the need for innovation.
    Thorax. 2022;77:636-637.
    PubMed        

  46. DAYNES E, Greening N, Singh SJ
    Randomised controlled trial to investigate the use of high-frequency airway oscillations as training to improve dyspnoea (TIDe) in COPD.
    Thorax. 2022;77:690-696.
    PubMed         Abstract available

  47. COX NS, McDonald CF, Mahal A, Alison JA, et al
    Telerehabilitation for chronic respiratory disease: a randomised controlled equivalence trial.
    Thorax. 2022;77:643-651.
    PubMed         Abstract available

  48. CHENG YJ, Chen ZG, Yao FJ, Liu LJ, et al
    Airflow obstruction, impaired lung function and risk of sudden cardiac death: a prospective cohort study.
    Thorax. 2022;77:652-662.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: